SIENNA BIOPHARMACEUTICALS INC (SNNA) Stock Price, Quote, News and Overview
NASDAQ:SNNA - Nasdaq -
SNNA Quote, Performance and Key Statistics
0.1358
+0.03 (+34.46%)
The current stock price of SNNA is 0.1358 null. In the past month the price decreased by -35.33%. In the past year, price decreased by -95.04%.
About SNNA
Company Profile
Sienna Biopharmaceuticals Inc. is a medical dermatology and aesthetics company. It provides products for inflammatory skin diseases, tissue injury and unwanted light-pigmented hair reduction. The company operates primarily in the United States and Italy. Sienna Biopharmaceuticals Inc. is based in Westlake Village, United States.
Company Info
SIENNA BIOPHARMACEUTICALS INC
30699 Russell Ranch Road Suite 140
Westlake Village CA 91362
CEO: Frederick C. Beddingfield III
Phone: 818-629-2256
SIENNA BIOPHARMACEUTICALS INC / SNNA FAQ
What is the stock price of SIENNA BIOPHARMACEUTICALS INC today?
The current stock price of SNNA is 0.1358 null. The price increased by 34.46% in the last trading session.
What is the ticker symbol for SIENNA BIOPHARMACEUTICALS INC stock?
The exchange symbol of SIENNA BIOPHARMACEUTICALS INC is SNNA and it is listed on the Nasdaq exchange.
On which exchange is SNNA stock listed?
SNNA stock is listed on the Nasdaq exchange.
What is SIENNA BIOPHARMACEUTICALS INC worth?
SIENNA BIOPHARMACEUTICALS INC (SNNA) has a market capitalization of 4.20M null. This makes SNNA a Nano Cap stock.
What are the support and resistance levels for SIENNA BIOPHARMACEUTICALS INC (SNNA) stock?
SIENNA BIOPHARMACEUTICALS INC (SNNA) has a resistance level at 0.17. Check the full technical report for a detailed analysis of SNNA support and resistance levels.
Should I buy SIENNA BIOPHARMACEUTICALS INC (SNNA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SNNA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SNNA, evaluating the profitability, health, valuation and growth aspects
- SIENNA BIOPHARMACEUTICALS INC (SNNA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SIENNA BIOPHARMACEUTICALS INC (SNNA) Sales and EPS estimates to see what analysts future expectations are.
- SIENNA BIOPHARMACEUTICALS INC (SNNA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SIENNA BIOPHARMACEUTICALS INC (SNNA) Insider and Institutional Ownership to learn about the owners and their transactions.
- SIENNA BIOPHARMACEUTICALS INC (SNNA) Stock Chart to make your own analysis
- SIENNA BIOPHARMACEUTICALS INC (SNNA) Latest news and press-releases to stay up to date.
Does SIENNA BIOPHARMACEUTICALS INC (SNNA) stock pay dividends?
SNNA does not pay a dividend.
What is the Price/Earnings (PE) ratio of SIENNA BIOPHARMACEUTICALS INC (SNNA)?
SIENNA BIOPHARMACEUTICALS INC (SNNA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.03).
SNNA Technical Analysis
SNNA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SNNA. While SNNA seems to be doing ok healthwise, there are quite some concerns on its profitability.
SNNA Financial Highlights
Over the last trailing twelve months SNNA reported a non-GAAP Earnings per Share(EPS) of -2.0300000000000002. The EPS increased by 37.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -110.25% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
SNNA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 100% to SNNA. The Buy consensus is the average rating of analysts ratings from 2 analysts.